Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review

J Dtsch Dermatol Ges. 2019 Feb;17(2):123-136. doi: 10.1111/ddg.13691. Epub 2018 Dec 3.

Abstract

Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder (PCSMP-TLPD) is a provisional entity with uncertain malignant potential according to the latest revision of the WHO classification for lymphoid neoplasms. We conducted a systematic literature review of all previously reported cases of PCSMP-TLPD to highlight their typical and atypical features. The main features of PCSMP-TLPD and its possible clinicopathologic overlap with similar disorders are also discussed. It is hoped that this review will provide a useful outline of this condition and the most important differential diagnoses. Finally, we recommend a rigorous consensus among cutaneous lymphoma experts in drafting diagnostic criteria and the best case definition.

Publication types

  • Systematic Review

MeSH terms

  • Adult
  • Aged
  • CD4-Positive T-Lymphocytes / pathology*
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry / methods
  • Lymphoma, T-Cell, Cutaneous / pathology*
  • Lymphoproliferative Disorders / chemically induced
  • Lymphoproliferative Disorders / diagnostic imaging
  • Lymphoproliferative Disorders / epidemiology
  • Lymphoproliferative Disorders / pathology*
  • Male
  • Meta-Analysis as Topic
  • Middle Aged
  • Prognosis
  • Skin Diseases / pathology
  • Skin Neoplasms / pathology*
  • Ultrasonography, Doppler, Color / methods